Andreas Strüngmann: Difference between revisions

Content deleted Content added

Inline

Revision as of 14:07, 4 February 2006

Andreas Strüngmann (1950-). Founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. In February 2005, he and his brother sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion.

This business-related biographical article is a stub. You can help Wikipedia by expanding it.

Revision as of 17:53, 22 June 2005 edit Joy (talk \| contribs) Autopatrolled, Administrators 143,848 edits m stub sort ← Previous edit		Revision as of 14:07, 4 February 2006 edit undo D6 (talk \| contribs) 393,081 edits m adding category:Living people Next edit →
Line 10:		Line 10:

	[[Category:1950 births\|Strüngmann, Andreas]]		[[Category:1950 births\|Strüngmann, Andreas]]
			[[Category:Living people\|Strüngmann, Andreas]]